参考文献

［1］FURMAN S，ROBINSON G. The use of an intracardiac pacemaker in the correction of total heart block. Surg Forum，1958，9：245-248.

［2］FURMAN S，PARKER B，ESCHER DJ. Decreasing electrode size and increasing efficiency of cardiac stimulation. J Surg Res，1971，11（3）：105-110.

［3］GREATBATCH W，LEE JH，MATHIAS W，et al. The solid-state lithium battery：a new improved chemical power source for implantable cardiac pacemakers. IEEE Trans Biomed Eng，1971，18（5）：317-323.

［4］SLOTWINER D，VARMA N，AKAR JG，et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm，2015，12（7）：e69-100.

［5］MABO P，VICTOR F，BAZIN P，et al. A randomized trial of long-term remote monitoring of pacemaker recipients（the COMPAS trial）.Eur Heart J，2012，33（9）：1105-1111.

［6］VARMA N，EPSTEIN AE，IRIMPEN A，et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up：the Lumos-T Safely Reduces Routine Office Device Follow-up（TRUST）trial. Circulation，2010，122（4）：325-332.

［7］CROSSLEY GH，BOYLE A，VITENSE H，et al. The CONNECT（Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision）trial：the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol，2011，57（10）：1181-1189.

［8］GUéDON-MOREAU L，LACROIX D，SADOUL N，et al. A randomized study of remote follow-up of implantable cardioverter defibrillators：safety and efficacy report of the ECOST trial. Eur Heart J，2013，34（8）：605-614.

［9］GUéDON-MOREAU L，LACROIX D，SADOUL N，et al. Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study. Europace，2014，16（8）：1181-1188.

［10］HINDRICKS G，TABORSKY M，GLIKSON M，et al. Implant-based multiparameter telemonitoring of patients with heart failure（IN-TIME）：a randomised controlled trial. Lancet，2014，384（9943）：583-590.

［11］LANDOLINA M，PEREGO GB，LUNATI M，et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators：the evolution of management strategies of heart failure patients with implantable defibrillators（EVOLVO）study. Circulation，2012，125（24）：2985-2992.

［12］刘文亨，陈柯萍，宿燕岗，等.远程监测系统在国内心血管植入型电子器械患者中的应用评价.中华心律失常学杂志，2016，20（6）：481-485.

［13］张炜，党爱民，樊晓寒，等.扩张型心肌病心脏性猝死患者临床特征分析.中华心律失常学杂志，2016，20（3）：207-211.

［14］KUSUMOTO FM，SCHOENFELD MH，BARRETT C，et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay：a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation，2019，140（8）：e382-e482.

［15］CHEN K，LI Y，DAI Y，et al. Comparison of electrocardiogram characteristics and pacing parameters between left bundle branch pacing and right ventricular pacing in patients receiving pacemaker therapy. Europace，2019，21（4）：673-680.

［16］BHATT AG，MUSAT DL，MILSTEIN N，et al. The efficacy of His bundle pacing：lessons learned from implementation for the first time at an experienced electrophysiology center. JACC Clin Electrophysiol，2018，4（11）：1397-1406.

［17］DESHMUKH P，CASAVANT DA，ROMANYSHYN M，et al. Permanent，direct His-bundle pacing：a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation，2000，101（8）：869-877.

［18］REDDY VY，EXNER DV，CANTILLON DJ，et al. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med，2015，373（12）：1125-1135.

［19］REYNOLDS DW，RITTER P. A leadless intracardiac transcatheter pacing system. N Engl J Med，2016，374（26）：2604-2605.